ATE236893T1 - Substituierte tetracyclische tetrahydrofuranderivate - Google Patents

Substituierte tetracyclische tetrahydrofuranderivate

Info

Publication number
ATE236893T1
ATE236893T1 AT97920662T AT97920662T ATE236893T1 AT E236893 T1 ATE236893 T1 AT E236893T1 AT 97920662 T AT97920662 T AT 97920662T AT 97920662 T AT97920662 T AT 97920662T AT E236893 T1 ATE236893 T1 AT E236893T1
Authority
AT
Austria
Prior art keywords
6alkyl
pct
zero
independently
optionally substituted
Prior art date
Application number
AT97920662T
Other languages
English (en)
Inventor
Pilar Gil-Lopetegui
Francisco Javi Fernandez-Gadea
Theo Franz Meert
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8223868&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE236893(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE236893T1 publication Critical patent/ATE236893T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT97920662T 1996-04-12 1997-04-09 Substituierte tetracyclische tetrahydrofuranderivate ATE236893T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96200990 1996-04-12
PCT/EP1997/001829 WO1997038991A1 (en) 1996-04-12 1997-04-09 Substituted tetracyclic tetrahydrofuran derivatives

Publications (1)

Publication Number Publication Date
ATE236893T1 true ATE236893T1 (de) 2003-04-15

Family

ID=8223868

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920662T ATE236893T1 (de) 1996-04-12 1997-04-09 Substituierte tetracyclische tetrahydrofuranderivate

Country Status (30)

Country Link
US (3) US6057441A (de)
EP (1) EP0892793B1 (de)
JP (1) JP3199751B2 (de)
KR (1) KR100389298B1 (de)
CN (1) CN1116291C (de)
AT (1) ATE236893T1 (de)
BG (1) BG63083B1 (de)
BR (1) BR9706639A (de)
CA (1) CA2232141C (de)
CY (1) CY2382B1 (de)
CZ (1) CZ288865B6 (de)
DE (1) DE69720709T2 (de)
DK (1) DK0892793T3 (de)
EA (1) EA001002B1 (de)
EE (1) EE03612B1 (de)
ES (1) ES2196328T3 (de)
HK (1) HK1015771A1 (de)
HU (1) HUP9901613A3 (de)
IL (1) IL123655A (de)
MY (1) MY119321A (de)
NO (1) NO317156B1 (de)
NZ (1) NZ329953A (de)
PL (1) PL190960B1 (de)
PT (1) PT892793E (de)
SI (1) SI0892793T1 (de)
SK (1) SK283400B6 (de)
TR (1) TR199801164T2 (de)
TW (1) TW504506B (de)
WO (1) WO1997038991A1 (de)
ZA (1) ZA973114B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ329953A (en) * 1996-04-12 1999-06-29 Janssen Pharmaceutica Nv Substituted tetracyclic n-oxide tetrahydrofuran derivatives, salts and stereoisomeric forms thereof for the treatment of cns cardiovascular or gastrointestinal disorders
UA52778C2 (uk) 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
US20050148018A1 (en) 1999-10-07 2005-07-07 David Weiner Methods of identifying inverse agonists of the serotonin 2A receptor
HRP20000310A2 (en) * 2000-05-17 2002-02-28 Pliva Farmaceutska Ind Dioniko New dibenzoazulene compounds as tumor necrosis factor inhibitors
WO2002056873A2 (en) * 2000-12-22 2002-07-25 Bayer Pharmaceuticals Corporation 2-substituted dibenzo[a,e]1,2,3-triazolo[4,5-c][7]annulen-8-ones as growth hormone secretagogues
UA79248C2 (en) * 2001-11-09 2007-06-11 Janssen Pharmaceutica Nv Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
CA2468040A1 (en) 2001-12-07 2003-06-12 Janssen Pharmaceutica N.V. Preparation of cis-fused 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives
ATE294168T1 (de) 2001-12-07 2005-05-15 Janssen Pharmaceutica Nv Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivaten
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20030160A2 (en) * 2003-03-06 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. 1-thiadibenzoazulene derivatives and biological action thereof
HRP20030885A2 (en) * 2003-11-03 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS
HRP20030956A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU
HRP20030953A2 (en) * 2003-11-21 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030954A2 (en) * 2003-11-21 2005-08-31 Pliva D.D. USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030957A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030955A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030958A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,3-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20040104A2 (en) * 2004-01-30 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
AR049512A1 (es) * 2004-06-14 2006-08-09 Janssen Pharmaceutica Nv Derivados de tetrahidrofurano tetraciclicos. composiciones farmaceuticas
CA2568752C (en) 2004-06-23 2013-05-07 Janssen Pharmaceutica N.V. Novel unsaturated tetracyclic tetrahydrofuran derivatives
AU2011202995B2 (en) * 2004-12-07 2012-02-02 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
AU2005313325C1 (en) 2004-12-07 2011-11-10 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
US7915249B2 (en) 2005-01-27 2011-03-29 Janssen Pharmaceutical Nv Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HT2 inhibitors in the treatment of CNS disorders
US20080214572A1 (en) * 2005-05-19 2008-09-04 Francisco Javier Fernandez-Gadea Selected Tetracyclic Tetrahydrofuran Derivatives Containing a Cyclic Amine Side Chain
CA2604165A1 (en) * 2005-05-26 2006-11-30 Janssen Pharmaceutica N.V. Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
CA2611443C (en) * 2005-06-17 2014-08-26 Janssen Pharmaceutica N.V. Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
DE2742794A1 (de) * 1976-11-15 1978-05-18 Dec Int Vorrichtung zur befoerderung von gemahlenem kaese
DE68924751T2 (de) * 1988-09-26 1996-04-11 Smithkline Beecham Farma Azacyclische Verbindungen, verwendbar als Arzneimittel.
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
FR2681320B1 (fr) * 1991-09-12 1994-01-14 Synthelabo Derives de n-(4,7dimethoxyindan-2-yl)-1-(phenylcarbonyl)-n-propyl-piperidine-4-methanamine, leur preparation et leur application en therapeutique.
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
ATE256110T1 (de) * 1995-09-15 2003-12-15 Neurosearch As Piperindinverbindungen als calcium-kanal-blocker
NZ329953A (en) * 1996-04-12 1999-06-29 Janssen Pharmaceutica Nv Substituted tetracyclic n-oxide tetrahydrofuran derivatives, salts and stereoisomeric forms thereof for the treatment of cns cardiovascular or gastrointestinal disorders

Also Published As

Publication number Publication date
SI0892793T1 (en) 2003-10-31
DE69720709D1 (de) 2003-05-15
NZ329953A (en) 1999-06-29
HK1015771A1 (en) 1999-10-22
EA199800348A1 (ru) 1998-10-29
CZ324398A3 (cs) 1999-01-13
US6288058B1 (en) 2001-09-11
TW504506B (en) 2002-10-01
KR100389298B1 (ko) 2003-10-30
NO981076D0 (no) 1998-03-11
US6194405B1 (en) 2001-02-27
IL123655A0 (en) 1998-10-30
PL190960B1 (pl) 2006-02-28
EE9800326A (et) 1999-04-15
AU712154B2 (en) 1999-10-28
JP3199751B2 (ja) 2001-08-20
US6057441A (en) 2000-05-02
SK283400B6 (sk) 2003-07-01
DE69720709T2 (de) 2004-03-11
PT892793E (pt) 2003-08-29
HUP9901613A3 (en) 2001-08-28
CY2382B1 (en) 2004-06-04
NO317156B1 (no) 2004-08-30
CA2232141C (en) 2006-05-23
SK141898A3 (en) 1999-03-12
BR9706639A (pt) 1999-01-12
KR19990067514A (ko) 1999-08-25
PL328575A1 (en) 1999-02-01
ES2196328T3 (es) 2003-12-16
EP0892793A1 (de) 1999-01-27
CA2232141A1 (en) 1997-10-23
WO1997038991A1 (en) 1997-10-23
HUP9901613A2 (hu) 1999-09-28
CZ288865B6 (cs) 2001-09-12
BG63083B1 (bg) 2001-03-30
EE03612B1 (et) 2002-02-15
AU2695997A (en) 1997-11-07
NO981076L (no) 1998-10-09
IL123655A (en) 2001-03-19
EA001002B1 (ru) 2000-08-28
BG102820A (en) 1999-08-31
JP2000508327A (ja) 2000-07-04
DK0892793T3 (da) 2003-07-21
CN1205006A (zh) 1999-01-13
EP0892793B1 (de) 2003-04-09
CN1116291C (zh) 2003-07-30
TR199801164T2 (xx) 1998-10-21
MY119321A (en) 2005-05-31
ZA973114B (en) 1998-10-12

Similar Documents

Publication Publication Date Title
DK0892793T3 (da) Substituerede tetracykliske tetrahydrofuranderivater
CA2305612A1 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
TW333532B (en) Benzopyrans
NZ329954A (en) Isoxazolidine tetracyclic and tricyclic ring system derivatives and medicaments
MY113325A (en) Substituted tetracyclic azepine derivatives
SE9701396D0 (sv) Compounds
PL319870A1 (en) Derivatives of tetracyclic substituted oxazepin and thiazepin exhibiting affinity in respect to 5-ht2 receptors
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
CA2232195A1 (en) Isoxazolidine derivatives
MX9703250A (es) Derivados tetraciclicos de oxazepina y tiazepina sustituidos con afinidad al receptor de 5-ht2.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0892793

Country of ref document: EP